Company Data
DiaMedica Therapeutics Inc.
Ticker
DMAC
Current Price
$7.98 -2.56%
Market Cap
$415.6M
Price Target
Refer to Report
Volume
474.4K
52wk Range
$3.19 - $9.23
Overview
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. It is principally engaged in the business activity of developing treatments for unmet clinical need or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.